COMPASS Pathways launches phase II clinical trial of psilocybin therapy in...

Silo Pharma Announces Positive Results from its Topically Administered Formulation of...

Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement

Braxia Scientific Bolsters Leadership with Strategic Hires; Adds Chief Information Officer...

U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With...

COMPASS Pathways plc to announce second quarter 2022 financial results on...

PT341 – Monnica Williams, Ph.D. – Racism, Trauma, Research, and Psychedelics

Ecstasy for the 21st Century: Designer Drugs to Improve MDMA Therapy

HAVN Life Announces Financing Commitment of CAD$9,000,000 through the issuance of...

Incannex Receives Ethics Approval to Commence Phase 1 Clinical Trial of...

Load more